¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Myopathy due to other toxic agents"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • centronuclear myopathy
    Áß½ÉÇÙ±Ù(À°)º´(Áõ)
  • mitochondrial myopathy
    »ç¸³Ã¼±Ù(À°)º´(Áõ)
  • myopathy
    ±Ù(À°)º´(Áõ)
  • naturally toxic plant
    ÀÚ¿¬µ¶¼º½Ä¹°
  • potentially toxic compound
    ÀáÀçµ¶¼º¹°Áú
  • streptococcal toxic shock syndrome
    »ç½½¾Ë±Õµ¶¼º¼îÅ©ÁõÈıº, ¿¬¼â±¸±Õµ¶¼º¼îÅ©ÁõÈıº
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myopathy
    ±ÙÀ°º´Áõ
  • toxic agent
    µ¶¹°, µ¶±Ø¹°
  • toxic erythema
    Áßµ¶È«¹Ý
  • toxic nodule
    µ¶¼º°áÀý
  • toxic epidermal necrolysis
    µ¶¼ºÇ¥ÇDZ«»ç¿ëÇØ
  • toxic substance
    µ¶¼º¹°Áú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • centronuclear myopathy
    Áß½ÉÇÙ±ÙÀ°º´Áõ
  • myopathy
    ±ÙÀ°º´Áõ
  • mitochondrial myopathy
    »ç¸³Ã¼±ÙÀ°º´Áõ
  • toxic agent
    µ¶¹°, µ¶±Ø¹°
  • toxic alopecia
    µ¶¼ºÅ»¸ðÁõ
  • toxic amaurosis
    Áßµ¶Èæ¾Ï½Ã
  • toxic amblyopia
    µ¶¼º¾à½Ã
  • toxic atrophy
    Áßµ¶À§Ãà
  • potentially toxic compound
    ÀáÀçµ¶¼º¹°Áú
  • toxic cardiopathy
    Áßµ¶½ÉÀ庴Áõ
  • toxic cataract
    Áßµ¶¹é³»Àå
  • toxic conjunctivitis
    µ¶¼º°á¸·¿°
  • toxic convulsion
    Áßµ¶°æ·Ã
  • toxic liver cirrhosis
    µ¶¼º°£°æÈ­(Áõ)
  • toxic deafness
    µ¶¼º³­Ã»
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • psychosis, toxic
    µ¶¹°Á¤½Åº´, Áßµ¶Á¤½Åº´.
  • Chemosensitizing agents
    È­ÇÐÀû °¨°¢Á¦
  • H2 recepor blocking agents, for ulcers
    H2¼ö¿ëüÂ÷´ÜÁ¦(â¥é»ô÷ó´Ó¨ð¥)
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • health care agents
    °Ç°­°ü¸®¿ä¿ø(ÊÙËíËô), °Ç°­°ü¸®±â±¸.
  • immunosuppressive agents
    ¸é¿ª¾ïÁ¦ÀÎÀÚ(¡­åäð¤ì×í­)
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(¡­ÐÉÜ»ñø).
  • progressive myopathy
    ÁøÇ༺ ±Ùº´Áõ(òäú¼àõ ÐÉÜ»ñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • jaundice due to biliary stasis
    ´ãÁó¿ïü¼º Ȳ´Þ(ÓÅñðê¦ôòàõüÜÓ¸).
  • atypical, mixed or other personality
    ºñÁ¤Çü ³»Áö È¥ÀçÇü ¶Ç´Â ±âŸ ÀΰÝ
  • shock and other somatic treatment
    Ãæ°Ý ¹× ±âŸ ½Åüġ·á
  • biologic agents
    »ý¹°ÇÐÀûÁ¦Á¦
  • eaton agents
    ÀÌÆ° º´¿øÃ¼
  • health care agents
    °Ç°­°ü¸®¿ä¿ø(ÊÙËíËô), °Ç°­°ü¸®±â±¸.
  • immunosuppressive agents
    ¸é¿ª¾ïÁ¦ÀÎÀÚ(¡­åäð¤ì×í­)
  • law for control of poisonous and powerful agents
    µ¶±Ø¹°Ãëü¹ý(ËÄË»ËŅ̬̃ ËÑ).
  • oral hypoglycemic agents
    °æ±¸´ç´¢º´¾àÁ¦(ÌèÏ¢ÓØèñÜ»å·ð¥).
  • oral hypoglycemic agents
    °æ±¸´ç´¢º´¾àÁ¦(ÌèÏ¢ÓØèñÜ»å·ð¥).
  • proteolytic agents
    ´Ü¹éºÐÇØÁ¦(¡­ÝÂú°ð¥).
  • skin protective agents
    ÇǺκ¸È£Á¦.
  • skin test agents
    ÇǺιÝÀÀ¾à(ù«Ý±Úãëëå·).
  • spermicidal agents
    »ìÁ¤Á¦(߯ïñð¥).
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ(¡­ÐÉÜ»ñø).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • median toxic dose
    Á¤Áß µ¶¼º·®(ïáñéÔ¸àõÕá)
  • psychotropic agents
    Á¤½ÅÀÛ¿ë¾à(ïñãêíÂéÄå·)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nodular toxic goiter
    °áÀý¼ºÁßµ¶¼º°©»ó¼±Á¾
  • toxic
    µ¶¼ºÀÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TS Takayasu syndrome; Tay-Sachs; temperature sensitivity; temperature, skin; temporal stem; tensile str...
HCM Hypertrophic Cardio-Myopathy
  = HCMP
OHA Oral Hypoglycemic Agents
CTA Canadian Tuberculosis Association; chemotactic activity; chromotropic acid; Committee on Thrombolyti...
d/t due to
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DUE DNA unwinding element
DUE Drug usage evaluation
CNM Centronuclear myopathy
CWA Chemical warfare agents
DBA Dentin bonding agents
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • G72.2
    Myopathy due to other toxic agents
    ±âŸ µ¶¼º¹°Áú¿¡ ÀÇÇÑ ±ÙÀ°º´Áõ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • jaundice due to biliary stasis
    ´ãÁó ¿ïü¼º Ȳ´Þ
  • form-other
    Çü½Ä»óÀÇ ¸ñ
  • other abnormality
    ±âŸ ÀÌ»ó
  • other craniofacial disorder
    ´Ù¸¥ µÎ°³ ¾È¸é Àå¾Ö
  • other facial structure
    ´Ù¸¥ ¾È¸é ±¸Á¶¹°
  • other mycoses
    ±âŸ Áø±ÕÁõ
  • acute myopathy
    ±Þ¼º ±Ùº´Áõ
  • centronuclear myopathy
    Áß½ÉÇÙ ±Ùº´Áõ
    Áß¾Ó¿¡ ÇÙÀÌ ÀÖ´Â ±Ù¼¶À¯°¡ ÅÂ¾Æ ±Ù¼¶À¯ÀÇ Æ¯Â¡ÀÎ ±Ù¼¼°ü
  • chloroquine myopathy
    Ŭ·Î·ÎŲ ±Ùº´Áõ
  • fingerprint body myopathy
    Áö¹® ¼Òü ±Ùº´Áõ
    ´ë´ÜÈ÷ µå¹® ÁúȯÀ¸·Î À¯¾Æ±âºÎÅÍÀÇ Àü½ÅÀû ±Ù ¼è¾à, À§Ãà, Àú±äÀåµµ¿Í Áö´É ÀúÇϰ¡ ³ªÅ¸³­´Ù. º´¸®Á¶Á÷ÇÐÀûÀ¸·Î ÀÛÀº À§ÃàµÈ ¼¶À¯¸¦ º¼ ¼ö ÀÖÀ¸¸ç ÀüÀÚÇö¹Ì°æ»ó¿¡¼­ ±Ù ¼¶À¯ÀÇ ¸·°ú ¼öÃà ¹°Áú »çÀÌ¿¡ ƯÀÌÇÑ ºÀÀÔü¸¦ º¸À̴µ¥ ÀÌ ºÀÀÔü´Â ¸·À¸·Î ½ÎÀÌÁö ¾Ê°í º¹ÀâÇÑ ÃþÆÇ ¹è¿­ÀÌ ¸¶Ä¡ Áö¹®°°ÀÌ º¸À̰í ÀÌ·¯ÇÑ ÃþÆÇµéÀº Åé´Ï °°Àº µ¹ÃâÀ» °®°í ÀÖ´Ù.
  • myotubular myopathy
    ±Ù ¼¼°ü¼º ±ÙÁõ
    ¼±Ãµ¼º ºñÁøÇ༺ ±Ù Àå¾Ö·Î ±Ù ¼¶À¯ÀÇ Á߽ɿ¡ ÀåÃàÀ» µû¶ó¼­ ÀÏ·Ä·Î ¹è¿­ÇÏ´Â Á᫐ ÇÙÀÌ ´ë´Ù¼öÀÇ ±Ù ¼¶À¯¿¡ ÀÎÁ¤µÇ´Â °ÍÀÌ Æ¯Â¡À¸·Î Å»ý±âÀÇ ±Ù°ü°ú À¯»çÇÑ Á¡¿¡¼­ ¸í¸íµÇ¾ú´Ù. Á᫐ ÇÙ ÁÖº¯¿¡ ±Ù¿ø¼¶À¯°¡ °á¿©µÈ ºÎºÐÀÌ ÀÖ´Â °æ¿ìµµ ÀÖ´Ù. ±Ù ±äÀå ÀúÇÏ, ¿îµ¿ ¹ß´ÞÀÇ Áö¿¬, ±Ù·Â ÀúÇÏ, ¾È°Ë Çϼö, ¾È¸é±Ù, ¿Ü¾È±Ù, °æ±Ù µîµµ ħ¹üµÈ´Ù. Ç÷û CPK´Â Á¤»óÀ̰ųª °æµµÀÇ »ó½ÂÀ» ³ªÅ¸³½´Ù.
  • nemaline myopathy
    ³×¸»¸°, °£¼Òü
  • allergic-toxic contact stomatitis
    ¾Ë·¯Áö-µ¶¼º Á¢ÃË ±¸³»¿°
  • nodular toxic goiter
    °áÀý¼º Áßµ¶¼º °©»ó¼±Á¾
  • toxic action
    µ¶ ÀÛ¿ë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
other-directed Pertaining to a person readily influenced by the attitudes of others.
(05 Mar 2000)
transferases (other substituted phosphate groups) <enzyme> A class of enzymes that transfers substituted phosphate groups.
Registry number: EC 2.7.8
(12 Dec 1998)
due date The estimated calendar date when a baby will be born, the date the baby is due to be born. It is also called the estimated date of confinement (EDC).
(12 Dec 1998)
dystonia, focal, due to blepharospasm The second most common focal dystonia, the involuntary, forcible closure of the eyelids. The first symptoms may be uncontrollable blinking. Only one eye may be affected initially, but eventually both eyes are usually involved. The spasms may leave the eyelids completely closed causing functional blindness even though the eyes and vision are normal.
(12 Dec 1998)
dystonia, focal, due to torticollis Spasmodic torticollis, or torticollis, is the most common of the focal dystonias. In torticollis, the muscles in the neck that control the position of the head are affected, causing the head to twist and turn to one side. In addition, the head may be pulled forward or backward.
(12 Dec 1998)
thrombotic disease due to protein c deficiency Protein C is a protein in plasma that enters into the cascade of biochemical events leading to the formation of a clot. Deficiency of protein c results in thrombotic (clotting) disease and excess platelets with recurrent thrombophlebitis (inflammation of the vein that occurs when a clot forms). The clot can break loose and travel through the blood stream (thromboembolism) to the lungs causing a pulmonary embolism, brain causing a stroke (cerebrovascular accident), heart causing an early heart attack, skin causing what in the newborn is called neonatal purpura fulminans, the adrenal gland causing haemorrhage with abdominal pain, abnormally low blood pressure (hypotension), and salt loss. Protein c deficiency is due to possession of one gene (heterozygosity) in chromosome band 2q13-14. The possession of two such genes (homozygosity) is usually lethal.
(12 Dec 1998)
carcinomatous myopathy <syndrome> A condition characterised by muscle weakness that is similar to the symptoms of myasthenia gravis. For this reason, it has been referred to as myasthenic syndrome. This disorder is caused by an insufficient release of neurotransmitter (acetylcholine) by the nerve cells. Unlike myasthenia gravis, as muscle contractions are continued, strength will increase. The cause of Lambert-Eaton syndrome is unknown, but is usually associated with small cell carcinoma of the lung or an autoimmune illness.
(27 Sep 1997)
centronuclear myopathy Slowly progressive generalised muscle weakness and atrophy beginning in childhood; on biopsy of skeletal muscle, the nuclei of most muscle fibres are seen to be located near the centre of a small fibre (the normal position for a 10-week embryo) rather than at the periphery of the fibre; familial incidence. Autosomal dominant recessive and X-linked [310400] forms occur.
Synonym: myotubular myopathy.
Distal myopathy, myopathy affecting predominantly the distal portions of the limbs; onset is usually after age 40, with weakness and wasting of small muscles of the hands; The infantile form and the Swedish later-onset are autosomal dominant and there is a Japanese late-onset type that is recessive.
Minicore-multicore myopathy, an uncommon nonprogressive myopathy with early onset, proximal weakness, and hypotonia. Muscle fibres show focal defects of oxidative and myofibrillar adenosine triphosphatase enzymes with disorganization of myofibril ultrastructure.
Mitochondrial myopathy, weakness and hypotonia of muscles, primarily those of the neck, shoulder, and pelvic girdles, with onset in infancy or childhood; on biopsy, giant, bizarre mitochondria are seen located between muscle fibrils just beneath the sarcolemma. The dominant form is due to deletion of mitochondrial DNA and the recessive form is due to a complex deficiency.
(05 Mar 2000)
rod myopathy A congenital myofibrillar abnormality in which small threadlike or rod-shaped bodies are scattered through the muscle fibres. It is marked by hypotonia and proximal muscle weakness. It is also called rod myopathy with reference to the threadlike (greek nema, thread) rods or myofibrils (latin fibrilla, a little fibre or threadlike structure).
(12 Dec 1998)
myopathy <neurology> Any disease of a muscle.
Origin: Gr. Pathos = disease
(18 Nov 1997)
myotubular myopathy Slowly progressive generalised muscle weakness and atrophy beginning in childhood; on biopsy of skeletal muscle, the nuclei of most muscle fibres are seen to be located near the centre of a small fibre (the normal position for a 10-week embryo) rather than at the periphery of the fibre; familial incidence. Autosomal dominant recessive and X-linked [310400] forms occur.
Synonym: myotubular myopathy.
Distal myopathy, myopathy affecting predominantly the distal portions of the limbs; onset is usually after age 40, with weakness and wasting of small muscles of the hands; The infantile form and the Swedish later-onset are autosomal dominant and there is a Japanese late-onset type that is recessive.
Minicore-multicore myopathy, an uncommon nonprogressive myopathy with early onset, proximal weakness, and hypotonia. Muscle fibres show focal defects of oxidative and myofibrillar adenosine triphosphatase enzymes with disorganization of myofibril ultrastructure.
Mitochondrial myopathy, weakness and hypotonia of muscles, primarily those of the neck, shoulder, and pelvic girdles, with onset in infancy or childhood; on biopsy, giant, bizarre mitochondria are seen located between muscle fibrils just beneath the sarcolemma. The dominant form is due to deletion of mitochondrial DNA and the recessive form is due to a complex deficiency.
(05 Mar 2000)
nemaline myopathy A congenital myofibrillar abnormality in which small threadlike or rod-shaped bodies are scattered through the muscle fibres. It is marked by hypotonia and proximal muscle weakness. It is also called rod myopathy with reference to the threadlike (greek nema, thread) rods or myofibrils (latin fibrilla, a little fibre or threadlike structure).
(12 Dec 1998)
ocular myopathy A specific type of slowly worsening weakness of the ocular muscles, usually associated with a pigmentary retinopathy.
See: Kearns-Sayre syndrome, oculopharyngeal dystrophy.
Synonym: ocular myopathy.
(05 Mar 2000)
thyrotoxic myopathy Extreme muscular weakness in severe thyrotoxicosis affecting muscles of limbs and trunk as well as those used in speech and swallowing.
(05 Mar 2000)
megacolon, toxic Acute dilatation of the colon associated with amebic or ulcerative colitis. The dilatation may precede perforation of the colon.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • toxic
    À¯µ¶ÇÑ
  • toxic
    (Áß)µ¶ÀÇ
  • due
    Á¤´çÇÑ,-¿¡ ÀÇÇÑ,Á¤È®È÷
  • due
    ÀÀ´çÄ¡·¯¾ßÇÒ;ÀÀ´ç;¿¡ µ¹¿©¾ßÇÒ;ÇÒ ¿¹Á¤ÀÎ;´ç¿¬ÇÒ;Á¤½ÄÀ¸·Î;¶§°¡ ¿À¸é;¸¶¶¥È÷;¼¼±Ý
  • due bill
    Â÷¿ë Áõ¼­
  • due date
    ¾îÀ½ÀÇ ¸¸±âÀÏ
  • due process
    (¹ý)Á¤´çÇÑ ¹ýÀÇ ÀýÂ÷(¹Ì±¹ Çå¹ý Á¦ 5Á¶,Á¦ 14Á¶)
  • postage due
    ¿ìÆí ¿ä±Ý ºÎÁ·
  • each other
    ¼­·Î
  • in some way or other
    ¾î¶»°Ô ÇØ¼­µçÁö
  • other
    ±×¹ÛÀÇ
  • some other time
    ¾ðÁ¨°¡ µý³¯¿¡(=some other day)
  • t'other
    ¶Ç Çϳª
  • A.N. Other
    ÀÍ¸í¾¾;¼±¼ö ¹ÌÁ¤
  • other
    µý;´Ù¸¥;´ÙÀ½ÀÇ;³ª¸ÓÁöÀÇ;every ~ Çϳª°É·¯;none ~ than ´Ù¸§ ¾Æ´Ñ;the ~ day(night)ÀÏÀü(¿äÀü³¯ ¹ã)¿¡;the ~ party »ó´ë¹æ;the ~ side (¹Ì±¹¿¡¼­ º») À¯·´;the ~ world ³»¼¼;Àú½Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á